Sarah has spent her career informing strategic decision-making across the biopharmaceutical industry. Her work has spanned due diligence, partnering and fundraising, drug and franchise strategy, pricing and market access, and overall corporate and business development strategy for biotech and pharmaceutical clients. Her prior experience includes consulting at ClearView Healthcare Partners, where she conducted consulting engagements across most major therapeutic areas. She spent several years researching stem cell behaviour at the Harvard Stem Cell Institute and graduated summa cum laude with her B.A. in Human Developmental and Regenerative Biology from Harvard University
